Pancragen Research Guide

Full name: Pancragen (Lys-Glu-Asp-Trp Pancreas Bioregulator)

A short synthetic peptide bioregulator from the Khavinson family targeted at pancreatic tissue. Used in the bioregulator community to support pancreatic function and glucose/metabolic regulation in short repeated courses.

How Pancragen Works

As a signal peptide (Lys-Glu-Asp-Trp), it is proposed to regulate gene expression in pancreatic tissue, supporting normal endocrine and exocrine pancreatic function and carbohydrate metabolism.

Dosing Protocol

• Typical dose: ~1-2 capsules/day or short injectable courses
• Frequency: Once daily
• Duration: 10-30 day courses
• Route: Oral capsule or subcutaneous

Reported Benefits

• Pancreatic tissue support
• Carbohydrate metabolism support (proposed)
• Metabolic resilience
• Short course-based protocol

Potential Side Effects

• Limited Western clinical data
• Injection site reactions (injectable)
• Unknown long-term effects

Research Citations

1. Pancreatic peptide bioregulators (2015) - Reported to support pancreatic tissue function and carbohydrate metabolism in regional research studies.

Related Weight Management Compounds

• AOD-9604 - Full Profile
• Semaglutide - Full Profile
• Tirzepatide - Full Profile
• Retatrutide - Full Profile
• Tesofensine - Full Profile
• CagriSema - Full Profile

View full Pancragen profile with 3D molecule viewer →